Shrinks In Sneakers

Tag: mental health matters

  • Inflammation: The Hidden Culprit Behind Your Mental Health Struggles

    Inflammation: The Hidden Culprit Behind Your Mental Health Struggles

    Over the past several years, a growing body of research has highlighted the role of inflammation in the development and progression of psychiatric disorders. A key biomarker frequently used in these studies is C-reactive protein (CRP), which can be measured through a simple blood test. For precise results, it’s important to order the ultra-sensitive CRP test when conducting this in a lab setting.

    Recent findings from JAMA Psychiatry have revealed varying mental health trajectories for individuals with low-grade inflammation throughout childhood. Persistently elevated CRP levels, particularly peaking around age 9, were linked to an increased risk of developing psychosis, severe depression, and insulin resistance in adolescence and early adulthood.

    This research suggests that a simple blood test could potentially identify children at higher risk for serious mental illnesses and cardiometabolic issues later in life, offering a window for early intervention.

    The big question remains: how should we address this low-grade inflammation? My first recommendation is to focus on lifestyle modifications, particularly dietary changes that reduce inflammation, such as adopting a Mediterranean diet. Additionally, I believe chronic stress is a major contributor to inflammation. In modern American society, stress reduction is often overlooked, but finding effective ways to manage stress is crucial to mitigating long-term health risks.

    Link to the article: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2822343

  • The ketogenic Diet For Mental Health

    The ketogenic Diet For Mental Health

    The ketogenic diet, primarily known for its benefits in weight loss and managing conditions like epilepsy, has been increasingly explored for its potential impact on mental health, including psychiatry. While research in this area is still emerging, some studies suggest that the ketogenic diet may offer benefits for certain psychiatric conditions. 

    1. Mood Disorders: Some research indicates that the ketogenic diet might have a positive impact on mood disorders such as depression and bipolar disorder. The diet’s ability to stabilize blood sugar levels and regulate neurotransmitters like serotonin and dopamine could contribute to mood improvement.
    2. Anxiety: The ketogenic diet’s effects on GABA (gamma-aminobutyric acid), a neurotransmitter that helps regulate anxiety, have been of interest to researchers. By increasing GABA levels, the diet may have an anxiolytic effect, potentially reducing symptoms of anxiety.
    3. Cognitive Function: Ketones produced during ketosis are an alternative fuel source for the brain. Some studies suggest that ketones may provide more efficient energy for brain cells, leading to improved cognitive function and clarity of thought. This could have implications for conditions such as ADHD and cognitive impairment.
    4. Neuroprotective Effects: Ketones have been shown to have neuroprotective properties, which could be beneficial in neurodegenerative disorders like Alzheimer’s disease and Parkinson’s disease. By providing an alternative energy source for the brain, the ketogenic diet may help protect against neuronal damage and promote brain health.
    5. Inflammation: Chronic inflammation has been linked to various psychiatric disorders. The ketogenic diet has anti-inflammatory effects, which could potentially reduce inflammation in the brain and mitigate symptoms of conditions like schizophrenia and PTSD.
    6. Gut-Brain Axis: Emerging research suggests that the gut microbiota plays a crucial role in mental health. The ketogenic diet can influence the gut microbiome, potentially improving gut health and modulating brain function through the gut-brain axis.

    While these findings are promising, it’s essential to approach the use of the ketogenic diet in psychiatry with caution. More research, including large-scale clinical trials, is needed to fully understand its efficacy, safety, and long-term effects on mental health conditions. Additionally, the ketogenic diet may not be suitable for everyone and should be implemented under the guidance of healthcare professionals, especially for individuals with pre-existing health conditions or those taking medications.

  • What Makes you a Doctor?

    What Makes you a Doctor?

    I came across a post from a CRNA claiming psychiatrists “aren’t real doctors” because they don’t intubate or run a vent. Apparently, their idea of being a doctor is exclusively working as a critical care physician. Sure, if you have a narrow view of what makes a doctor, maybe you’d agree.

    But let’s talk about what psychiatry really entails. Everyone thinks they could handle it—until mom’s hiding a knife under her pillow or someone who’s killed before is sitting across from you, manic and unpredictable. The truth is, most people in med school (or NP school) don’t sign up for that. Managing a vent? Intubating for surgery? Honestly, those sound like a vacation compared to digging deep into the chaos of the human mind.

    Practicing psychiatry right is no walk in the park. Sure, you could do it lazily and still get paid, but you’d be hurting patients and leaving messes for those of us who care. We deal with psychotic, dangerous, unpredictable individuals every day. And while it might not be as glamorous as a tube down someone’s throat, we are essential to every medical service. We do the dirty work, behind the scenes, keeping everyone safe.

    So next time someone’s in the ED or on the floor going completely bonkers, guess who steps in? The psychiatrist.

    And by the way—I still run codes and keep up my ACLS certification. Who knows, I might even toss in a tube if I’m feeling it. 😎 #PsychiatryIsMedicine #MentalHealthMatters #WeDoTheWorkNoOneElseWants

  • Ketamine: A Temporary Fix, Not a Cure for Depression

    Ketamine: A Temporary Fix, Not a Cure for Depression

    It’s crucial to understand that ketamine is not a cure for depression. Many individuals experience a relapse, often within 2 to 4 weeks after finishing the initial treatment. If you’re expecting ketamine to fully resolve your depression, this could lead to disappointment and potentially harmful consequences.

  • Doctor’s Near-Death Experience: The Truth Behind Antidepressant Withdrawal – Fact or Fiction

    Doctor’s Near-Death Experience: The Truth Behind Antidepressant Withdrawal – Fact or Fiction

    These sensational headlines about near-death experiences coming off antidepressants are becoming far too common. While we must be cautious with prescribing, it’s equally important not to dissuade people from trying medications that could help them.

    Yes, some patients experience withdrawal symptoms if medications are stopped abruptly without proper tapering. But many patients do not, and I’ve seen countless cases where people discontinue their antidepressants without any issues. Some may require prolonged tapers, while others can taper off much faster than alarmist articles would suggest.

    It’s crucial to remember that while discontinuation can be uncomfortable, it’s rarely life-threatening. We do need to be mindful of how long we prescribe these medications, given they manage symptoms but don’t modify the underlying disease, and the long-term benefits are still debated.

    Guidelines for deprescribing are helpful, but dramatic headlines about “nearly dying” when coming off these medications are not only inaccurate but harmful to those who could benefit from treatment. Let’s promote balanced, evidence-based discussion on this topic, focusing on proper discontinuation without sensationalizing the risks.

    Link to article: https://www.theguardian.com/australia-news/article/2024/jul/31/australian-doctor-mark-horowitz-who-almost-died-writes-landmark-guidance-on-how-to-safely-stop-using-antidepressants

  • Surge in Antidepressant Overdoses Alarms Health Experts Across the U.S

    Surge in Antidepressant Overdoses Alarms Health Experts Across the U.S

    Rising Antidepressant Overdoses: A Growing Concern in the U.S.

    Recent data reveals that antidepressant overdoses in the U.S. have been steadily increasing from 1999 through 2022. According to a CDC report released last month, there were 5,863 overdose deaths attributed to antidepressants in 2022—numbers comparable to heroin-related fatalities, which claimed 5,871 lives. While these figures represent a small fraction of the over 100,000 overdose deaths that year—most of which involved fentanyl—they signal a troubling trend that demands attention.

    Potential Causes for the Rise in Antidepressant Overdoses

    Understanding the root causes of this increase is challenging, given the complexity of overdose data and the lack of detail on the exact substances involved. However, there are several factors worth considering.

    First, many individuals with opioid use disorder (OUD) also suffer from co-occurring mental health conditions like depression and bipolar disorder. These patients are often prescribed antidepressants, sometimes too liberally, in my experience working in community mental health. When opioids are mixed with antidepressants, opioids are often the primary cause of death in overdoses. Yet, I’ve also encountered numerous patients who have attempted suicide using antidepressants alone.

    Newer antidepressants are generally safer in overdose compared to older drugs, such as monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs). While these older medications tend to be more effective, they come with significantly higher risks in overdose situations. This is something I frequently emphasize to residents: older drugs are more dangerous, but the newer ones, though safer, can still have serious consequences.

    Chronic pain patients, who are often prescribed opioids, are another vulnerable group. Their risk of suicide is heightened by the constant pain they endure, and many of these individuals are also prescribed antidepressants like duloxetine, which is indicated for pain management, or more dangerous TCAs such as amitriptyline and nortriptyline. Additionally, gabapentin—another drug commonly prescribed to these patients—has been known to increase the risk of death when taken with opioids.

    Overprescription of Antidepressants: A Contributing Factor?

    There has also been a sharp rise in antidepressant prescriptions across the U.S., which I believe warrants scrutiny. Antidepressants are, at best, symptom management tools, with a modest effect size of 0.33 in many studies. Given these limited benefits, we should be more judicious about who we prescribe these medications to and for how long.

    Withdrawal symptoms from long-term—and sometimes even short-term—use of antidepressants can be severe, increasing the risk of suicide. I’ve personally seen this with a family member who experienced debilitating headaches and vertigo after stopping sertraline. She was unable to work or function for nearly two weeks, highlighting how challenging withdrawal can be for some patients.

    Balancing Risks and Benefits in Mental Health Treatment

    Any population for whom antidepressants are considered a treatment option is inherently at high risk for suicide. That said, there are many confounding factors in the overdose data, and mainstream mental health reporting often glosses over the nuances of psychiatric research and treatment. When prescribing medications, it’s crucial to weigh not only the pros and cons of the drugs themselves but also to tailor treatment to each individual’s unique needs.

    I continue to prescribe antidepressants to patients whom I’ve carefully evaluated and believe will benefit, even if only in the short term. However, I am transparent with them: antidepressants are unlikely to resolve deeper psychological conflicts or “problems of living.” Mental health is rarely black and white, and much of this uncertainty stems from our incomplete understanding of the brain.

    In short, we need to acknowledge the complexity behind the rise in antidepressant overdoses and respond with a more nuanced, patient-centered approach to prescribing these medications.

    Link to the article:

    https://www.theguardian.com/science/article/2024/sep/03/antidepressants-overdose-deaths-increasing

  • Enlarged Brain Networks: A Hidden Signature of Depression from Childhood Onward

    Enlarged Brain Networks: A Hidden Signature of Depression from Childhood Onward

    The article “Frontostriatal salience network expansion in individuals in depression” highlights new research findings showing that individuals with depression have enlarged brain networks associated with emotional processing. The study, conducted on both children and adults, reveals that specific brain regions linked to depression display structural differences, with these regions being larger than those in non-depressed individuals.

    The researchers particularly focused on the amygdala and hippocampus, which are key to emotions and memory. This enlargement appears to start in childhood, suggesting early neurodevelopmental factors might contribute to the onset of depression later in life. The findings could lead to better understanding of depression’s biological roots and improve early detection and treatment strategies.

    Link to the article: https://www.nature.com/articles/s41586-024-07805-2

  • Hidden Dangers: Unveiling the Link Between Medical Conditions and Suicide Risk

    Hidden Dangers: Unveiling the Link Between Medical Conditions and Suicide Risk

    The article “Risk of Suicide Across Medical Conditions and the Role of Prior Mental Disorder” published in JAMA examines the association between various medical conditions and suicide risk, highlighting the influence of pre-existing mental disorders. Key findings include:

    1. Increased Suicide Risk in Certain Medical Conditions: The study identifies a significant rise in suicide risk among patients with specific conditions, such as cancer, chronic pain, neurological disorders, and respiratory diseases. Chronic illness often contributes to emotional distress, exacerbating the risk of suicide.
    2. Impact of Mental Health History: Individuals with a prior mental disorder are at an even higher risk of suicide when diagnosed with a medical condition. The presence of a mental disorder can amplify feelings of hopelessness, increasing vulnerability.
    3. Interconnected Nature of Physical and Mental Health: The research emphasizes the need for integrated care that addresses both the physical and psychological aspects of health, particularly for individuals with complex medical histories.

    The article advocates for more robust screening for suicidal ideation in patients with both medical and mental health conditions and suggests collaborative treatment approaches to reduce suicide risk.

    Link to article: https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2822967

  • Suicide Prevention: A Personal Commitment to Hope and Healing

    Suicide Prevention: A Personal Commitment to Hope and Healing

    I thought I would share one of my favorite songs (Eminem Beautiful) as I reflect on what suicide prevention means to me. 

    link to song if you haven’t heard it: https://www.youtube.com/watch?v=SBb11rmHLIY

    This past year has been one of the most challenging times of my life. I watched my 20-year relationship fall apart, missed crucial professional opportunities, and questioned nearly every decision I’ve ever made. To say I was struggling would be an understatement. What stung even more was the silence from people I thought were my friends—they never reached out, never asked how I was doing. It left me feeling hollow and alone.

    But instead of letting that break me, I took this as a chance to reflect on who my real friends are, and I focused on building myself—mind and body—stronger than ever. I refused to let this hardship define or defeat me.

    When patients tell me they’re at their breaking point, I understand that feeling. But I also know they’ve only tapped into a fraction of their strength. There’s so much more to give, more life to live. During dark times, it’s easy to feel unheard and invisible, but I promise you—I’m here, I’m listening, and we can get through anything.

    If you or someone you love is in a dark place, please reach out for help. You are not alone, and your story is far from over. Don’t ever let anyone tell you that you’re not beautiful—because you are.

  • Inpatient Psychiatry: Sanctuary for Healing or Profit-Driven Trap?

    Inpatient Psychiatry: Sanctuary for Healing or Profit-Driven Trap?

    The New York Times typically does a good job of investigating and reporting on mental health topics, but in this case, it seems they missed the mark, especially in representing inpatient psychiatry. Inpatient psychiatry is a challenging environment for both patients and physicians like myself. We never want to keep anyone in the hospital who doesn’t need to be there. In fact, when patients accuse me of holding them for financial gain, I tell them that I’m paid the same regardless of the number of cases I manage, and my life is easier with fewer patients. No physician working in inpatient care would ever keep someone confined without a legitimate safety concern for the patient or the community. While no one defends poor practices, and Arcadia may indeed have its issues, the broader implications of articles like this one deserve closer scrutiny. The article lacks detail, avoids expert input from professionals in the field, and fails to account for the fact that dangerousness might emerge during hospitalization, potentially converting a voluntary patient to involuntary status or necessitating a more cautious discharge approach that could save lives.

    Here’s the reality: people are admitted to inpatient psychiatric units for a variety of reasons. We can talk all day about the broken U.S. healthcare system and the lack of access to quality outpatient psychiatric care, but fundamentally, there are two main reasons someone ends up on an inpatient unit. First, they are a danger to themselves, and without close monitoring and treatment, they are at high risk of suicide. Second, they pose a danger to others, and without inpatient care, serious harm could come to someone else. We see plenty of cases that meet these clear criteria, and I believe that without our services, many of these individuals would either be dead or in jail. However, there are also other reasons why patients seek inpatient care, and the article’s example of a woman with bipolar disorder needing a medication adjustment is worth exploring.

    Why not see an outpatient psychiatrist for medication management? Why seek inpatient care from a doctor who doesn’t know your case? This situation can be dissected further. Suppose this patient, who doesn’t pose a threat to themselves or others, voluntarily enters an inpatient unit for treatment. Medication changes are made, lithium is increased, and as the treating physician, you would need at least 3-5 days for observation and lab work to monitor the effects. Given that this patient could have pursued outpatient treatment, it becomes your responsibility as the inpatient doctor to ensure proper monitoring and follow-up. But let’s say, after admission, you learn that the patient had been suicidal the week prior and had a plan to overdose. Now, there’s new information indicating a greater level of risk. If, after 24 hours, the patient suddenly wants to leave, as the physician, you must consider this new information. You ask to speak to the patient’s family to gather more context, but the patient refuses and demands discharge. In my state, the patient would file a formal 48-hour notice, which allows me 48 hours to assess if they pose an imminent danger. If so, a two-physician commitment process can be initiated.

    The point is that treating physicians must weigh numerous safety concerns—such as unfinished medication adjustments, potential emerging risks, and patients’ misunderstanding of the inpatient process. Mental health treatment often takes weeks to months to see full results, and if patients feel significantly better after just a few days, it’s either due to electroconvulsive therapy (ECT) or the placebo effect of being in a hospital setting. I believe it’s crucial for people to understand the role of inpatient psychiatric facilities, and I make it a point to educate my patients about why hospitalization is necessary and what they can expect. Many arrive with false assumptions about what can be accomplished in an inpatient setting.

    Link to New York Times Article: https://www.nytimes.com/2024/09/01/business/acadia-psychiatric-patients-trapped.html